CAS RN: 2757082-27-0
INDEX NAME NOT YET ASSIGNED
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
97%, 99%e.e. (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20251212
250mg / 1g
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 2757082-27-0
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Hong Kong
Inquiry
2757082-27-0 / (4R)-4-phenyl-2-[2-[(4R)-4-phenyl-4,5-dihydro-1,3-oxazol-2-yl]-1,3-dihydroinden-2-yl]-4,5-dihydro-1,3-oxazole
Standard CAS: 2757082-27-0
Multi CAS: No
Basic Information
copy
CAS
2757082-27-0 copy
Multi CAS
No copy
Molecular Formula
C27H24N2O2 copy
Molecular Weight
408.500000 copy
Exact Mass
408.183778 copy
InChI
InChI=1S/C27H24N2O2/c1-3-9-19(10-4-1)23-17-30-25(28-23)27(15-21-13-7-8-14-22(21)16-27)26-29-24(18-31-26)20-11-5-2-6-12-20/h1-14,23-24H,15-18H2/t23-,24-/m0/s1 copy
InChIKey
CXTGPFGXKVGOQY-ZEQRLZLVSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
31 copy
Aromatic heavy atom count
18 copy
Fraction Csp3
0.26 copy
Rotatable bonds
4 copy
H-bond acceptors
4 copy
Molar refractivity
121.42 copy
TPSA
43.18 copy
LogP / Solubility
WLOGP
5.11 copy
MLOGP
4.52 copy
XLogP3
4.7 copy
Consensus LogP
4.78 copy
Log S (ESOL)
-5.76 copy
Class (ESOL)
Slightly soluble copy
Log S (Ali)
-6.6 copy
Class (Ali)
Insoluble copy
Log S (SILICOS-IT)
-7.04 copy
Class (SILICOS-IT)
Insoluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
Yes copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-1.58 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
5 copy